Erratum: Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I (Oncogene (2003) 22 (1945-1954) DOI: 10.1038/sj.onc.1206214);Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I

Oncogene

Volumn 22, Issue 13, 2003, Pages 1945-1954

  Olivier, Ayrault ^a   Lucie, Karayan ^a   Jean François, Riou ^b   Christian Jacques, Larsen ^a   Paule, Séité ^a  

^a IBMIG Institut de Biologie Moleculaire et dIngenierie Genetique   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Cell cycle; P14ARF; Protein interactions; Topoisomerase I

Indexed keywords

DNA TOPOISOMERASE; PROTEIN P14; PROTEIN P14ARF;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXON; HUMAN; MOUSE; NONHUMAN; NUCLEOLUS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; ARMYWORM; BONE TUMOR; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; GENE DELETION; GENETIC TRANSFECTION; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; OSTEOSARCOMA; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; MAMMALIA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BONE NEOPLASMS; CELL NUCLEOLUS; CELLS, CULTURED; DNA TOPOISOMERASES, TYPE I; ENZYME ACTIVATION; GENES, P16; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; OSTEOSARCOMA; POINT MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SPODOPTERA; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0037417128     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209539     Document Type: Erratum

References (22)

1. Carnero A, Hudson JD, Price CM and Beach DH. (2000). Nat. Cell Biol., 2, 148-154.
2. Della Valle V, Duro D, Bernard O and Larsen CJ. (1997). Oncogene, 15, 2475-2481.
3. Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ and Brambilla E. (1998). Cancer Res. 58, 3926-3931.
4. Guldner HH, Szostecki C, Vosberg HP, Lakomek HJ, Penner E and Bautz FA. (1986). Chromosoma, 94, 132-138.
5. Hahn WC and Weinberg RA. (2002). Nat. Rev. Cancer, 2, 331-341.
6. Higuchi R, Krummel B and Saiki RK. (1988). Nucleic Acids Res., 16, 7351-7367.
7. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
8. Karayan L, Riou JF, Séité P, Migeon J, Cantereau A and Larsen CJ. (2001). Oncogene, 20, 836-848.
9. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 6630, 299-303.
10. Kurokawa K, Tanaka T and Kato J. (1999). Oncogene, 18, 2718-2727.
11. Llanos S, Clark PA, Rowe J and Peters G. (2001). Nat. Cell Biol., 3, 445-452.
12. Rizos H, Darmanian AP, Mann GJ and Kefford RF. (2000). Oncogene, 19, 2978-2985.
13. Rossi F, Labourier E, Forné T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C and Tazi J. (1996). Nature, 381, 80-82.
14. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
15. Sherr CJ. (1998). Genes Dev., 12, 2984-2991.
16. Sherr CJ. (2001). Nat. Rev. Mol. Cell. Biol., 10, 731-737 (review).
17. Vaughn JL, Goodwin RH, Tompkins GJ and McCawley P. (1977). In Vitro, 13, 213-217.
18. Weber JD, Taylor LJ, Roussel MF, Sher CJ and Bar-Sagi D. (1999). Nat. Cell Biol., 1, 20-26.
19. Weber JD, Jeffers JR, Tehg JE, Randle DH, Lozano G, Roussel MF, Scherr CJ and Zambetti GP. (2000). Genes Dev., 14, 2358-2365.
20. Wei W, Hemmer RM and Sedivy JM. (2001). Mol. Cell Biol., 21, 6748-6757.
21. Zhang Y and Xiong Y. (1999). Mol. Cell., 3, 579-591.
22. Zhang Y, Xiong Y. (2001). Cell Growth Differ., 12, 175-186.